Systemic Juvenile Idiopathic Arthritis (sJIA)

What is sJIA?

Systemic juvenile idiopathic arthritis (sJIA) is an autoinflammatory disease that causes swelling in the joints. In an autoinflammatory disease, such as sJIA, the immune system becomes active and begins to attack healthy cells and tissues. This results in inflammation of the joints causing them to become red, swollen, painful or hot to the touch and more widespread inflammation of the body resulting in features such as fever and rash.

Between 10% and 15% of all children with JIA have sJIA (source: AboutKidsHealth)

WEBINAR: Learn more about sJIA!

In this webinar hosted by our friends at Juvenile Arthritis Research (JAR), Dr. Paul Brogan gives an overview of sJIA, signs and symptoms of the condition, an overview of treatment pathways, as well as what to look out for in the early signs of a flare and when to seek help.

NOTE: Information provided in this discussion about processes related to drug/treatment approval and access to specific medications (i.e. Canakinumab) is based on the UK healthcare system and may differ from the Canadian healthcare system.

additional resources

AboutKidsHealth:
AboutKidsHealth is a health education website for children, youth and their caregivers from the experts at SickKids Hospital. The website offers a variety of sJIA and JIA resources for parents and youth.

Systemic JIA Foundation:
The Systemic JIA Foundation is a US-based non-profit dedicated to accelerating research & treatment for Systemic JIA (Systemic Juvenile Idiopathic Arthritis), also known as Still’s Disease and associated complications such as Macrophage Activation Syndrome.